Considering the role of OPN and Grem1 in the pathogenesis mechanisms of ischemic heart disease-induced HF, targeting OPN and Grem1 as the possible diagnostic and therapeutic agents can create an alternative option in the attempts to optimize the individual patient-focused healthcare strategy for ischemic HF patients. This evidence concerns the gene SPP1 and hydrops fetalis.